Quintás-Cardama A - Search Results

1

Dasatinib early intervention after cytogenetic or hematologic resistance to imatinib in patients with chronic myeloid leukemia.

Quintás-Cardama A, Cortes JE, O'Brien S, Ravandi F, Borthakur G, Liu D, Bleickardt E, Chen TT, Kantarjian HM. Quintás-Cardama A, et al. Cancer. 2009 Jul 1;115(13):2912-21. doi: 10.1002/cncr.24325. Cancer. 2009. PMID: 19402171 Free PMC article.

2

Bosutinib for the treatment of chronic myeloid leukemia in chronic phase.

Quintás-Cardama A, Kantarjian H, Cortes J. Quintás-Cardama A, et al. Drugs Today (Barc). 2012 Mar;48(3):177-88. doi: 10.1358/dot.2012.48.3.1750274. Drugs Today (Barc). 2012. PMID: 22462037 Review.

3

Granulocyte-colony-stimulating factor (filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase chronic myelogenous leukemia.

Quintas-Cardama A, Kantarjian H, O'Brien S, Garcia-Manero G, Rios MB, Talpaz M, Cortes J. Quintas-Cardama A, et al. Cancer. 2004 Jun 15;100(12):2592-7. doi: 10.1002/cncr.20285. Cancer. 2004. PMID: 15197801 Free article.

4

Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia.

Quintas-Cardama A, Kantarjian H, Talpaz M, O'Brien S, Garcia-Manero G, Verstovsek S, Rios MB, Hayes K, Glassman A, Bekele BN, Zhou X, Cortes J. Quintas-Cardama A, et al. Blood. 2005 Mar 15;105(6):2281-6. doi: 10.1182/blood-2004-06-2208. Epub 2004 Nov 30. Blood. 2005. PMID: 15572595 Free article. Clinical Trial.

5

Kinase inhibitors in chronic myelogenous leukemia.

Quintás-Cardama A, Cortes J. Quintás-Cardama A, et al. Clin Adv Hematol Oncol. 2006 May;4(5):365-74. Clin Adv Hematol Oncol. 2006. PMID: 16728945

6

Adaphostin has significant and selective activity against chronic and acute myeloid leukemia cells.

Orsolic N, Golemovic M, Quintás-Cardama A, Scappini B, Manshouri T, Chandra J, Basic I, Giles F, Kantarjian H, Verstovsek S. Orsolic N, et al. Cancer Sci. 2006 Sep;97(9):952-60. doi: 10.1111/j.1349-7006.2006.00269.x. Epub 2006 Jul 4. Cancer Sci. 2006. PMID: 16822295 Free PMC article.

7

Chronic myeloid leukemia: diagnosis and treatment.

Quintás-Cardama A, Cortes JE. Quintás-Cardama A, et al. Mayo Clin Proc. 2006 Jul;81(7):973-88. doi: 10.4065/81.7.973. Mayo Clin Proc. 2006. PMID: 16835977 Review.

8

Novel approaches in the treatment of systemic mastocytosis.

Quintas-Cardama A, Aribi A, Cortes J, Giles FJ, Kantarjian H, Verstovsek S. Quintas-Cardama A, et al. Cancer. 2006 Oct 1;107(7):1429-39. doi: 10.1002/cncr.22187. Cancer. 2006. PMID: 16948123 Free article. Review.

9

Activity of 9-nitro-camptothecin, an oral topoisomerase I inhibitor, in myelodysplastic syndrome and chronic myelomonocytic leukemia.

Quintas-Cardama A, Kantarjian H, O'Brien S, Jabbour E, Giles F, Ravandi F, Faderl S, Pierce S, Shan J, Verstovsek S, Cortes J. Quintas-Cardama A, et al. Cancer. 2006 Oct 1;107(7):1525-9. doi: 10.1002/cncr.22186. Cancer. 2006. PMID: 16955510 Free article. Clinical Trial.

10

Dasatinib (BMS-354825) is active in Philadelphia chromosome-positive chronic myelogenous leukemia after imatinib and nilotinib (AMN107) therapy failure.

Quintas-Cardama A, Kantarjian H, Jones D, Nicaise C, O'Brien S, Giles F, Talpaz M, Cortes J. Quintas-Cardama A, et al. Blood. 2007 Jan 15;109(2):497-9. doi: 10.1182/blood-2006-07-035493. Epub 2006 Sep 21. Blood. 2007. PMID: 16990591 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters